SCHEMBL4130145

SCHEMBL4130145

COc1ccccc1C(O)c1cc(Cl)ccc1-n1cccc1C=CC(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.40
MAPT P10636 2/20 0.39
PLA2G1B P04054 1/20 0.39
ATG4B Q9Y4P1 1/20 0.39
FDFT1 P37268 3/20 0.37
LMNA P02545 2/20 0.36
KDM4E B2RXH2 2/20 0.36
RECQL P46063 2/20 0.35
HPGD P15428 2/20 0.35
NPC1 O15118 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
GPR55 Q9Y2T6 1/20 0.35
LPAR1 Q92633 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
ALDH1A1 P00352 1/20 0.34
ALOX15 P16050 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4130138 1.00 GAA (0.40) GAAMAPTPLA2G1BATG4BFDFT1
SCHEMBL4112300 0.93 FDFT1 (0.41) GAAMAPTFDFT1KDM4EALDH1A1
SCHEMBL4112306 0.93 FDFT1 (0.41) GAAMAPTFDFT1KDM4EALDH1A1
SCHEMBL4133617 0.92 KDM4E (0.36) GAAMAPTPLA2G1BATG4BFDFT1
SCHEMBL4133613 0.92 KDM4E (0.36) GAAMAPTPLA2G1BATG4BFDFT1
SCHEMBL13775445 0.91 GAA (0.40) GAAMAPTFDFT1LMNAKDM4E
SCHEMBL4110619 0.90 FDFT1 (0.39) MAPTFDFT1KDM4EALDH1A1SMN1; SMN2
SCHEMBL4110617 0.90 FDFT1 (0.39) MAPTFDFT1KDM4EALDH1A1SMN1; SMN2
SCHEMBL4110419 0.87 FDFT1 (0.34) FDFT1CTSA
SCHEMBL4110425 0.87 FDFT1 (0.34) FDFT1CTSA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
EP-1939205-A1 TRICYCLIC COMPOUND Daiichi Sankyo Company, Limited (JP) 2008-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181942-A1 TRICYCLIC COMPOUNDS FDFT1, COASY, HMGCR GAA 922/4885MAPT 4428/4885PLA2G1B 1610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.